Improved mammalian vectors for high expression of G418 resistance.
- 1 January 1987
- journal article
- research article
- Published by Japan Society for Cell Biology in Cell Structure and Function
- Vol. 12 (6) , 575-580
- https://doi.org/10.1247/csf.12.575
Abstract
Cell lines, such as those of teratocarcinoma an embryonic stem cells, fail to support high G418 resistance after transfection of neo vectors. To alleviate this, we modified pSV2-neo in two steps, first with tandem promoters of SV40 early genes and HSVtk, then by removing an improper met codon located immediately upstream of the authentic initiator codon in the mRNA sequence. In the final product, pSTneoB, the neo transcription unit has XhoI sites at both ends. pSTneoB yields G418-resistant transformants of teratocarcinoma cells at dramatically higher efficiencies than pSV2-neo. This vector extends the application of G418 selection in gene transfer to a wider range of cell types.This publication has 7 references indexed in Scilit:
- Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomesCell, 1986
- Differentiation-dependent expression of the chicken delta-crystallin gene introduced into mouse teratocarcinoma stem cells.The EMBO Journal, 1984
- Nucleotide sequence and exact localization of the neomycin phosphotransferase gene from transposon Tn5Gene, 1982
- High-frequency transfer of cloned herpes simplex virus type 1 sequences to mammalian cells by protoplast fusion.Molecular and Cellular Biology, 1981
- A new dominant hybrid selective marker for higher eukaryotic cellsJournal of Molecular Biology, 1981
- Direct transfer of cloned genes from bacteria to mammalian cells.Proceedings of the National Academy of Sciences, 1980
- Alterations in the developmental potential of embryonal carcinoma cells in mixed aggregates of nullipotent and pluripotent cellsCell, 1979